Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates
HAIFA, Israel, July 18, 2024 (GLOBE NEWSWIRE) — Leading biotechnology company Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) (“Pluri” or the “Company”), which […]
HAIFA, Israel, July 18, 2024 (GLOBE NEWSWIRE) — Leading biotechnology company Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) (“Pluri” or the “Company”), which […]
Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary […]
Paris, France – July 18, 2024 Viridien, formerly CGG, will announce its second quarter 2024 financial results on Tuesday, July […]
Paris, France – July 18, 2024 Résultats financiers du T2 2024 et conférence téléphonique Viridien, anciennement CGG, annoncera ses résultats […]
Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and […]
July 18, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the […]
SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) — SAI.TECH Global Corporation (“SAI.TECH” or “SAI” or the “Company”) (NASDAQ: SAI, SAITW), today […]
CALGARY, Alberta, July 17, 2024 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based energy […]
TORONTO, July 17, 2024 (GLOBE NEWSWIRE) — In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) (“Dundee”) announces that its […]
BEIJING, July 17, 2024 (GLOBE NEWSWIRE) — TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company”), a China-based insurance broker conducting […]